181 related articles for article (PubMed ID: 33528004)
1. Attenuating Treatment-Related Cardiotoxicity in Women Recently Diagnosed With Breast Cancer via a Tailored Therapeutic Exercise Program: Protocol of the ATOPE Trial.
Postigo-Martin P; Peñafiel-Burkhardt R; Gallart-Aragón T; Alcaide-Lucena M; Artacho-Cordón F; Galiano-Castillo N; Fernández-Lao C; Martín-Martín L; Lozano-Lozano M; Ruíz-Vozmediano J; Moreno-Gutiérrez S; Illescas-Montes R; Arroyo-Morales M; Cantarero-Villanueva I
Phys Ther; 2021 Mar; 101(3):. PubMed ID: 33528004
[TBL] [Abstract][Full Text] [Related]
2. Nonlinear, Multicomponent Physical Exercise With Heart Rate Variability-Guided Prescription in Women With Breast Cancer During Treatment: Feasibility and Preliminary Results (ATOPE Study).
González-Santos Á; Lopez-Garzon M; Gil-Gutiérrez R; Salinas-Asensio MDM; Postigo-Martin P; Cantarero-Villanueva I
Phys Ther; 2023 Sep; 103(9):. PubMed ID: 37347987
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol.
Díaz-Balboa E; González-Salvado V; Rodríguez-Romero B; Martínez-Monzonís A; Pedreira-Pérez M; Palacios-Ozores P; López-López R; Peña-Gil C; González-Juanatey JR
BMC Cardiovasc Disord; 2021 Apr; 21(1):165. PubMed ID: 33827450
[TBL] [Abstract][Full Text] [Related]
4. A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.
Jacquinot Q; Meneveau N; Chatot M; Bonnetain F; Degano B; Bouhaddi M; Dumoulin G; Vernerey D; Pivot X; Mougin F
BMC Cancer; 2017 Jun; 17(1):425. PubMed ID: 28629338
[TBL] [Abstract][Full Text] [Related]
5. Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial.
Antunes P; Esteves D; Nunes C; Sampaio F; Ascensão A; Vilela E; Teixeira M; Amarelo AL; Joaquim A
Trials; 2019 Jul; 20(1):433. PubMed ID: 31307527
[TBL] [Abstract][Full Text] [Related]
6. Effects of physical exercise on outcomes of cardiac (dys)function in women with breast cancer undergoing anthracycline or trastuzumab treatment: study protocol for a systematic review.
Antunes P; Esteves D; Nunes C; Amarelo A; Fonseca-Moutinho J; Afreixo V; Costa H; Alves A; Joaquim A
Syst Rev; 2019 Oct; 8(1):239. PubMed ID: 31651372
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Chemotherapy-Induced Peripheral Neuropathy With PRESIONA, a Therapeutic Exercise and Blood Flow Restriction Program: A Randomized Controlled Study Protocol.
Lopez-Garzon M; Cantarero-Villanueva I; Legerén-Alvarez M; Gallart-Aragón T; Postigo-Martin P; González-Santos Á; Lozano-Lozano M; Martín-Martín L; Ortiz-Comino L; Castro-Martín E; Ariza-García A; Fernández-Lao C; Arroyo-Morales M; Galiano-Castillo N
Phys Ther; 2022 Mar; 102(3):. PubMed ID: 35079838
[TBL] [Abstract][Full Text] [Related]
8. Feasibility study of a multimodal prehabilitation programme in women receiving neoadjuvant therapy for breast cancer in a major cancer hospital: a protocol.
Grant SJ; Kay S; Lacey J; Kumar S; Kerin-Ayres K; Stehn J; Gonzalez M; Templeton S; Heller G; Cockburn J; Wahlroos S; Malalasekera A; Mak C; Graham S
BMJ Open; 2024 Mar; 14(3):e080239. PubMed ID: 38508617
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer.
Kirkham AA; Paterson DI; Prado CM; Mackey JR; Courneya KS; Pituskin E; Thompson RB
BMC Cancer; 2018 Sep; 18(1):864. PubMed ID: 30176834
[TBL] [Abstract][Full Text] [Related]
10. Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.
Jacob S; Pathak A; Franck D; Latorzeff I; Jimenez G; Fondard O; Lapeyre M; Colombier D; Bruguiere E; Lairez O; Fontenel B; Milliat F; Tamarat R; Broggio D; Derreumaux S; Ducassou M; Ferrières J; Laurier D; Benderitter M; Bernier MO
Radiat Oncol; 2016 Apr; 11():54. PubMed ID: 27056179
[TBL] [Abstract][Full Text] [Related]
11. Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer.
Yu AF; Flynn JR; Moskowitz CS; Scott JM; Oeffinger KC; Dang CT; Liu JE; Jones LW; Steingart RM
JAMA Cardiol; 2020 Mar; 5(3):309-317. PubMed ID: 31939997
[TBL] [Abstract][Full Text] [Related]
12. Effect of a 1-year tailored exercise program according to cancer trajectories in patients with breast cancer: study protocol for a randomized controlled trial.
Ryu J; Lee EY; Min J; Yeon S; Lee JW; Chu SH; Lee H; Kim SI; Kim JY; Park S; Jeon JY
BMC Cancer; 2023 Mar; 23(1):200. PubMed ID: 36864418
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Toxicity from Breast Cancer Treatment: Can We Avoid This?
Caron J; Nohria A
Curr Oncol Rep; 2018 Jun; 20(8):61. PubMed ID: 29876677
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and outcomes of a goal-directed physical therapy program for patients with metastatic breast cancer.
Groen WG; Ten Tusscher MR; Verbeek R; Geleijn E; Sonke GS; Konings IR; Van der Vorst MJ; van Zweeden AA; Schrama JG; Vrijaldenhoven S; Bakker SD; Aaronson NK; Stuiver MM
Support Care Cancer; 2021 Jun; 29(6):3287-3298. PubMed ID: 33104921
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?
Barron CC; Tyagi NK; Alhussein MM; Mukherjee SD; Ellis PM; Dhesy-Thind S; Leong DP
Oncologist; 2019 Nov; 24(11):1405-1409. PubMed ID: 31315962
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Oncologist-Referred Exercise and Healthy Eating Programming as a Part of Supportive Adjuvant Care for Early Breast Cancer.
Kirkham AA; Van Patten CL; Gelmon KA; McKenzie DC; Bonsignore A; Bland KA; Campbell KL
Oncologist; 2018 Jan; 23(1):105-115. PubMed ID: 28982801
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer.
Matikas A; Margolin S; Hellström M; Johansson H; Bengtsson NO; Karlsson L; Edlund P; Karlsson P; Lidbrink E; Linderholm B; Lindman H; Malmstrom P; Villman K; Foukakis T; Bergh J
Breast Cancer Res Treat; 2018 Apr; 168(2):349-355. PubMed ID: 29190004
[TBL] [Abstract][Full Text] [Related]
18. High-intensity exercise prescription guided by heart rate variability in breast cancer patients: a study protocol for a randomized controlled trial.
Lavín-Pérez AM; Collado-Mateo D; Hinojo González C; de Juan Ferré A; Ruisánchez Villar C; Mayo X; Jiménez A
BMC Sports Sci Med Rehabil; 2023 Mar; 15(1):28. PubMed ID: 36890601
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity of Contemporary Breast Cancer Treatments.
Lee Chuy K; Yu AF
Curr Treat Options Oncol; 2019 May; 20(6):51. PubMed ID: 31073788
[TBL] [Abstract][Full Text] [Related]
20. Incidence and identification of risk factors for trastuzumab-induced cardiotoxicity in breast cancer patients: an audit of a single "real-world" setting.
Tang GH; Acuna SA; Sevick L; Yan AT; Brezden-Masley C
Med Oncol; 2017 Sep; 34(9):154. PubMed ID: 28779423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
